MinorXanthine oxidase inhibitors×Other dermatologicals (topical); peripheral vasodilators (systemic)
Updated · Methodology
Mechanism
Allopurinol inhibits the enzyme xanthine oxidase. Xanthine oxidase and aldehyde oxidase convert it into its active metabolite oxipurinol, which the kidneys excrete (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). In the liver, minoxidil is mainly conjugated with glucuronic acid. It does not bind to plasma proteins and causes no substantial change in glomerular filtration rate or renal plasma flow (minoxidil tablets SmPC, AEMPS). Between 1% and 2% of the applied dose of scalp foam or solution reaches the circulation (minoxidil scalp foam SmPC, AEMPS). No document names the pair, and the metabolic and elimination pathways the documents describe for the two drugs do not overlap.
Symptoms
The documents describe no symptoms of this combination. A common adverse effect of allopurinol is skin rash. Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, are rare and occur mostly in the first weeks of treatment (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Minoxidil on the scalp commonly causes itching, dermatitis, rash, headache and unwanted hair growth outside the scalp, and rarely palpitations and a fast heart rate. Minoxidil tablets cause salt and water retention, oedema and, in most people, increased body hair (minoxidil SmPCs, AEMPS).
Management
According to the documents, the combination is acceptable, and the doses of allopurinol and minoxidil need no change. No document names the pair (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and allopurinol label, US Food and Drug Administration, FDA; minoxidil SmPCs, AEMPS, and minoxidil tablets label, FDA). Stop allopurinol immediately at the first sign of rash or any other sign of hypersensitivity (allopurinol SmPC, AEMPS). Use allopurinol with care in people treated for hypertension or heart failure, because their kidney function may be impaired (allopurinol SmPC, AEMPS). In Spain, minoxidil tablets are used for severe hypertension that does not respond to usual treatment, and the scalp foam and solution for androgenetic alopecia (minoxidil SmPCs, AEMPS). In renal impairment, reduce the allopurinol dose, and minoxidil tablets may also need a lower dose (allopurinol and minoxidil tablets SmPCs, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Allopurinol tablet (Dr. Reddy's Laboratories Limited) – Prescribing Information (2018)– ; DailyMed setid 19a138b8-d225-03e6-f762-abe71560204b
- AEMPS: Ficha técnica Zyloric 100 mg (alopurinol) (2026)– AEMPS CIMA, Zyloric 100 mg comprimidos, nº registro 43775, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Minoxidil, Regaine 50 mg/g espuma cutánea (nº registro 76483), sección 4.4 (2025)– AEMPS, CIMA, nº registro 76483 (Regaine 50 mg/g espuma cutánea, JNTL Consumer Health), revisión 09/2025, secciones 4.1, 4.4, 4.5, 4.8 y 5.2
- AEMPS: Ficha técnica: Minoxidil, Loniten 10 mg comprimidos (nº registro 55636), sección 4.4 (2020)– AEMPS, CIMA, nº registro 55636 (Loniten 10 mg comprimidos, Pfizer), revisión 11/2020, secciones 4.1, 4.2, 4.4, 4.5 y 5.2
- FDA: Minoxidil tablets, Sun Pharmaceutical (minoxidil) prescribing information (2026)– FDA, DailyMed setid 0354a7f5-5917-44dc-9963-411104008cb5 (Sun Pharmaceutical Industries), versión 5, 02/2026, Warnings, Precautions (General, Drug interactions, Unapproved use), Clinical Pharmacology